Spectrum of mutations in the Batten disease gene, CLN3

American Journal of Human Genetics

Volumn 61, Issue 2, 1997, Pages 310-316

  Munroe, Patricia B ^a   Mitchison, Hannah M ^a   O'Rawe, Angela M ^a   Anderson, John W ^b   Boustany, Rose Mary ^c   Lerner, Terry J ^b   Taschner, Peter E M ^d   De Vos, Nanneke ^d   Breuning, Martijn H ^d   Gardiner, R Mark ^a   Mole, Sara E ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b HARVARD MEDICAL SCHOOL   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEROID; DNA; LIPOFUSCIN; PIGMENT; RNA;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ELECTRON MICROSCOPY; GENE; GENE DELETION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NEURONAL CEROID LIPOFUSCINOSIS; NONSENSE MUTATION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 16944364280     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/514846     Document Type: Article

References (22)

1. Amaral O, Fortuna AM, Lacerda L, Pinto R, Sa-Miranda MC (1994) Molecular characterisation of type 1 Gaucher disease families and patients: intrafamilial heterogeneity at the clinical level. J Med Genet 31:401-404
2. Antonarakis SE (1996) Recommendations for a nomenclature system for human gene mutations (http://ariel.ucs.uni-melb.edu.au:80/~cotton/antonara.htm)
3. Callen DF, Baker E, Lane S, Nancarrow J, Thompson A, Whitmore SA, MacLennan DH, et al (1991) Regional mapping of the Batten disease locus (CLN3) to human chromosome 16p12. Am J Hum Genet 49:1372-1377
4. Dean M, White MB, Amos J, Gerrard B, Stewart C, Khaw K-T, Leppert M (1990) Multiple mutations in highly conserved residues are found in mildly affected cystic fibrosis patients. Cell 61:863-870
5. Eiberg H, Gardiner RM, Mohr J (1989) Batten disease (Spielmeyer-Sjögren disease) and haptoglobins (HP): indication of linkage and assignment to chromosome 16. Clin Genet 36:217-218
6. Gardiner RM, Sandford A, Deadman M, Poulton J, Reeders S, Jokiaho I, Peltonen L, et al (1990) Batten disease (Spielmeyer-Vogt, juvenile-onset neuronal ceroid lipofuscinosis) gene (CLN3) maps to human chromosome 16. Genomics 8: 387-390
7. International Batten Disease Consortium, The (1995) Isolation of a novel gene underlying Batten disease (CLN3). Cell 82: 949-957
8. Janes RW, Munroe PB, Mitchison HM, Gardiner RM, Mole SE, Wallace BA (1996) A model for Batten disease protein CLN3: functional implications from homology and mutations. FEBS Lett 399:75-77
9. Lee RL, Johnson KR, Lerner TJ (1996) Isolation and chromosomal mapping of a mouse homolog of the Batten disease gene CLN3. Genomics 35:617-619
10. Lerner TJ, Boustany R-MN, MacCormack K, Gleitsman J, Schlumpf K, Breakefield XO, Gusella JF, et al (1994) Linkage disequilibrium between the juvenile neuronal ceroid lipofuscinosis gene and marker loci on chromosome 16p12.1. Am J Hum Genet 54:88-94
11. Mitchison HM, O'Rawe AM, Taschner PEM, Sandkuijl LA, Santavuori P, de Vos N, Breuning MH, et al (1995) Batten disease gene, CLN3: linkage disequilibrium mapping in the Finnish population, and analysis of European haplotypes. Am J Hum Genet 56:654-662
12. Mitchison HM, Taschner PEM, O'Rawe AM, De Vos N, Phillips HA, Thompson AD, Kozman HM, et al (1994) Genetic mapping of the Batten disease locus (CLN3) to the interval D16S288-D16S383 by analysis of haplotypes and allelic association. Genomics 22:465-468
13. Mitchison HM, Thompson AD, Mulley JC, Kozman HM, Richards RI, Callen DF, Stallings RL, et al (1993) Fine genetic mapping of the Batten disease locus (CLN3) by haplotype analysis and demonstration of allelic association with chromosome 16p microsatellite loci. Genomics 16:455-460
14. Mitchison HM, Munroe PB, O'Rawe AM, Taschner PEM, de Vos N, Kremmidiotis G, Lensink I, et al (1997) Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3. Genomics 40:346-350
15. Munroe PB, Rapola J, Mitchison HM, Mustonen A, Mole SE, Gardiner RM, Järvelä I (1996) Prenatal diagnosis of Batten's disease. Lancet 347:1014-1015
16. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
17. Sanger T, Nicklen S, Coulson AR (1977) DNA sequencing with chain termination inhibitors. Proc Natl Acad Sci USA 74:5463-5467
18. Santavuori P (1988) Neuronal ceroid lipofuscinosis in childhood. Brain Dev 10:80-83
19. Tyfield LA, Zschocke J, Stephenson A, Cockburn F, Harvie A, Bidwell JL, Wood NA, et al (1995) Discordant phenylketonuria phenotypes in one family: the relationship between genotype and clinical outcome is a function of multiple effects. J Med Genet 32:867-870
20. Wisniewski KE, Rapin I, Heaney-Kieras J (1988) Clinicopathological variability in the childhood neuronal ceroidlipofuscinoses and new observations on glycoprotein abnormalities. Am J Med Genet 5:27-46
21. Yan W, Boustany R-MN, Konradi C, Ozelius L, Lerner T, Troffater JA, Julier C, et al (1993) Localization of juvenile, but not late-infantile, neuronal ceroid lipofuscinosis on chromosome 16. Am J Hum Genet 52:89-95
22. Zeman W (1974) Studies in the neuronal ceroid lipofuscinosis. J Neuropathol Exp Neurol 33:1-12